Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1190)	7/8/2005 2:50:33 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CEGE Is tring to test the resistance from its June 20-June 21 double top at the 6.02 level. If it can close above that it may get to test the resistance from the May 11 H at 6.57 The stock seems to have found support at the 5.30 level and except for yesterday, all volume this month has been to the upside. The stock is up more than 6% today with volume already more than 520Ks. bigcharts.marketwatch.com Revenues in the March Q were down 36% and the loss/shr was $0.07 higher. It announced Tuesday that it has started a PIII of its lead product, GVAX vaccine, in patients with metastatic "hormone-refractory" prostatic Ca. Bernard